Table 2. Correlation analysis between patients’ clinicopathological features and CTNND2 expression.

Clinicopathological features	N	CTNND2 expression, n		P
		Positive (n=34)	Negative (n=12)
Age (years)				0.18
<55	22	14	8
≥55	24	20	4
Sex				0.51
Female	19	13	6
Male	27	21	6
Tumor ulcer				0.02
Yes	29	25	4
No	17	9	8
Lymphatic metastasis				0.003
Yes	19	18	1
No	27	16	11
TNM stage				0.049
I	11	6	5
II	16	10	6
III	8	7	1
IV	11	11	0
Tumor thickness (mm)				0.54
<1	8	6	2
1–4	25	17	8
>4	13	11	2

CTNND2, catenin delta 2; TNM, tumor-node-metastasis.